JEAN CAMPBELL is nationally recognized as one of the leading rare disease patient advocates with an impressive record of success in fundraising, patient advocacy and corporate relations. Jean served nearly two decades with the National Organization for Rare Disorders (NORD) in senior management positions including Vice President of Development. A well-respected resource in the rare disease community, Jean formed JF Campbell Consultants LLC, in 2010. Her vast expertise is valuable to all size companies and organizations. Jean’s consultancy has focused on the importance of creating, maintaining and advancing the patient advocacy function within the industry setting. Sharing the patient advocacy ‘tools of the trade’ which includes how to build effective relationships, delving into organizational landscapes and conducting patient advisory boards are just some of the ways that this function’s roles and responsibilities bring value and collaboration to a company’s internal goals. Jean is a co-founder and board member of the Professional Patient Advocates in Life Sciences (PPALS), which was created to meet the ever-growing needs of the ever-evolving patient advocacy function within industry. She coordinates PPALS programs as well as its annual Patient Advocacy Certificate Training (PACT) held in partnership with Sanford Research. Jean is a member of the Rare Collective and serves on the Erdheim-Chester Disease Global Alliance Board of Directors. Jean enjoys serving on MedunikCanada’s Advisory Board, Exceptional Parent Editorial Board, Sanford CoRDS’ External Advisory Board, and Our Odyssey’s Board of Directors. In May 2021, Jean was named a Patient Advocate Hero by Exceptional Parent Magazine during its 50th Anniversary celebration.